DESIGN: Two-center, prospective observational study.
SETTING: Mixed medical/surgical ICU in Japan.
PATIENTS: Nonsurgical adult patients who were expected to remain in ICU for greater than 5 days.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Urine samples were collected on days 1, 2, 3, 5, and 7 of ICU admission. To assess
muscle atrophy, rectus femoris cross-sectional area and diaphragm thickness were measured with ultrasound on days 1, 3, 5, and 7. Secondary outcomes included its relationship with ICU-acquired weakness, ICU Mobility Scale, and ICU mortality. Fifty-six patients and 232 urinary
titin measurements were included. Urinary
titin (normal range: 1-3 pmol/mg
creatinine) was 27.9 (16.8-59.6), 47.6 (23.5-82.4), 46.6 (24.4-97.6), 38.4 (23.6-83.0), and 49.3 (27.4-92.6) pmol/mg
creatinine on days 1, 2, 3, 5, and 7, respectively. Cumulative urinary
titin level was significantly associated with rectus femoris
muscle atrophy on days 3-7 (p ≤ 0.03), although urinary
titin level was not associated with change in diaphragm thickness (p = 0.31-0.45). Furthermore, cumulative urinary
titin level was associated with occurrence of ICU-acquired weakness (p = 0.01) and ICU mortality (p = 0.02) but not with ICU Mobility Scale (p = 0.18).
CONCLUSIONS: In nonsurgical
critically ill patients, urinary
titin level increased 10-30 times compared with the normal level. The increased urinary
titin level was associated with lower limb
muscle atrophy, occurrence of ICU-acquired weakness, and ICU mortality.